News Conference News SCAI 2019 Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib Yael L. Maxwell May 24, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News EAS 2018 Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention Yael L. Maxwell May 07, 2018
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Conference News AHA 2015 Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding Todd Neale November 10, 2015
News Conference News AHA 2015 CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure Shelley Wood November 08, 2015
News Conference News ESC 2015 OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES Caitlin E. Cox August 31, 2015
News Conference News ESC 2013 Length of DAPT, Reasons for Discontinuation Have Disparate Effects Yael L. Maxwell September 01, 2013
News Conference News ACC 2013 Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months Jason Kahn March 11, 2013
News Conference News AHA 2012 No Mortality Benefit with Prolonged Dual Antiplatelet Therapy November 05, 2012
News Conference News EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES Caitlin E. Cox April 05, 2011